Low-dose corticosteroids for immune-related hepatitis grade 2 clinical trials

Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids

This study looks at using a lower dose of steroids to treat liver problems (hepatitis) caused by cancer immunotherapy. It aims to see if this smaller dose works well, reducing side effects, and helping patients get better without needing stronger medicines.